Jun Jian Huang Selected Research

Neoplasms (Cancer)

1/2009	Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells.
2/2006	Cancer immunotherapy targeting the telomerase reverse transcriptase.
6/2002	Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Jian Huang Research Topics

Disease

3	Neoplasms (Cancer) 01/2009 - 06/2002
1	Carcinogenesis 07/2008

Drug/Important Bio-Agent (IBA)

4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2009 - 06/2002
1	EnzymesIBA 01/2009
1	Small Interfering RNA (siRNA)IBA 01/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2009
1	VaccinesIBA 02/2006
1	AntigensIBA 02/2006

Therapy/Procedure

1	Immunotherapy 02/2006
1	Therapeutics 06/2002